PHSC PLC - Aylesford, Kent-based company that provides health & safety consulting - Revenue for the six months ended September 30 is down 36% to GBP1.4 million from GBP2.2 million last year. Pretax profit slips 1.9% to GBP152,000 from GBP155,000. However, earnings before interest, tax, depreciation and amortisation in the period is GBP182,000, an increase of 4.0% compared with GBP175,000 in the same period last year. PHSC declares an interim dividend of 0.5 pence, unchanged from a year before, and says payment of final dividend will depend on its full-year performance and outlook at the time.
Current stock price: 13.50 pence
Year-to-date change: down 10%
By Zoe Wickens; zoewickens@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.


(Sharecast News) - PHSC said on Monday that it has completed the disposal of its freehold property at Raunds, Northamptonshire, for gross cash proceed...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued this week and not separately reported...


LONDON (Alliance News) - Health, safety, hygiene and environmental consultant PHSC PLC saw its shares rise Thursday after it said operating profit and...


LONDON (Alliance News) - Consultancy services and health and safety provider PHSC PLC Monday reported an increase in both earnings and sales for the n...


Health and safety training company PHSC reported a 79 per cent rise in first half turnover of 3.94m pounds. Earnings before interest, tax, depreciati...


Health and safety services provider PHSC reported a rise in revenues and profits Friday, as the group reaped rewards from two acquisitions. The grou...


HaiKe Chemical Group, a petrochemical, specialty chemical and biochemical business based in China, has purchased a minority stake in Dongying Hi-Tech ...


William Humphries, Chief Executive Officer of Patagonia Gold, the Argentina-focused mining firm, has purchased 300,000 shares in the firm. The direct...


Verona Pharma, respiratory diseases treatment developer, is initiating a new higher dose trial of its lead drug, RPL554, in patients with asthma, afte...


LONDON (Dow Jones)--PHSC PLC (PHSC.LN), a health, safety, asbestos, hygiene and environmental consultancy company, announced Wednesday it made a 6% ri...